Fact CheckerSign in

NCT07497126Active, not recruiting

The Prevalance of Malnutrition and Its Association With Disability in Patients With Relapsing-Remitting Multiple Sclerosis

The Prevalence of Malnutrition and Its Association With Disability in Patients With Relapsing-Remitting Multiple Sclerosis: A Prospective Cross-Sectional Observational Study

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

This prospective observational study aims to determine the prevalence of malnutrition in patients with relapsing-remitting multiple sclerosis and to evaluate its association with disability. Nutritional status will be assessed using the Mini Nutritional Assessment-Short Form, and body composition will be evaluated with bioelectrical impedance analysis and anthropometric measurements. The study will also assess urinary incontinence, depression, and anger-related features, and compare the findings with those of healthy controls.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
169 (actual)
First submitted
19 Mar 2026
Start date
Nov 2024
Primary completion date
Jan 2026
Lead sponsor
Antalya Training and Research Hospital
NCT number
NCT07497126

What you commit to

  • Study type: Observational
  • Participants enrolled: 169
  • From Nov 2024 to the primary completion date, Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of musculoskeletal disease
  • History of neuromuscular junction disease

Other

  • EDSS score ≥7 in the relapsing-remitting multiple sclerosis group
  • Multiple sclerosis relapse during the last 30 days
  • Systemic glucocorticoid treatment during the last 30 days

Who the study is looking for

  • Age 18 years or older
  • Diagnosis of relapsing-remitting multiple sclerosis for the patient group
  • Absence of another medical condition that markedly impairs walking, such as severe cardiovascular disease, respiratory disease, or major orthopedic conditions
  • Healthy volunteers willing to participate as controls
  • Written informed consent provided

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Antalya Training and Research Hospital
Coordinator of this site? Confirm its status
AntalyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.